By InvitationNot Applicable

Effects of Flavor Modification for Management of Radiation Induced Dysgeusia

United States30 participantsStarted 2024-09-08

Plain-language summary

Intervention for dysgeusia in head and neck cancer patients undergoing radiation therapy. This research proposal aims to investigate potential benefits of mBerry in improving quality of life and nutritional outcome in head and neck cancer patients' post-radiation therapy. Our hypothesis is that cancer patients undergoing radiation therapy will benefit from use of miracle berry in treatment of dysgeusia.

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Over 18 years * Diagnosis of mandibular cancer, tonsillar cancer, and lingual cancer * Receiving primary or adjuvant radiation therapy Exclusion Criteria: * Received a total glossectomy or total laryngectomy. * Patients with allergies to peanut, latex, peach, or soy will be excluded as they are at increased risk of allergy to mBerry. * Diagnosis of diabetes as well as prediabetic patients and those that are taking Metformin.

What they're measuring

5-Point Hedonic Rating Scale

Timeframe: Bi-weekly for 8 weeks

Chemotherapy-induced Taste Alteration Scale (CITAS)

Timeframe: Bi-weekly for 8 weeks

Trial details

NCT IDNCT06311877

SponsorUniversity of South Florida

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12-14

View on ClinicalTrials.gov More Dysgeusia trials